Earnings Feed
Start Free
Home/Filings/4/0001104659-06-001045
4//SEC Filing

MARTENSSON PEROLAF 4

Accession 0001104659-06-001045

CIK 0001013351other
View on SEC.govCompany Profile

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 6:52 PM ET

Size

38.7 KB

Accession

0001104659-06-001045

Insider Transaction Report

Form 4
Period: 2006-01-04
MAXIM PHARMACEUTICALS INCMAXM
MARTENSSON PEROLAF
Director
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−50,000→ 0 total
    Exercise: $8.00Exp: 2009-10-26→ Common Stock (50,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−40,000→ 0 total
    Exercise: $3.75Exp: 2008-03-02→ Common Stock (40,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−15,000→ 0 total
    Exercise: $15.75Exp: 2011-07-20→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−30,000→ 0 total
    Exercise: $5.20Exp: 2009-06-02→ Common Stock (30,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−5,000→ 0 total
    Exercise: $9.25Exp: 2009-06-02→ Common Stock (5,000 underlying)
  • Disposition to Issuer

    Common Stock

    2006-01-04−333→ 0 total
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−20,000→ 0 total
    Exercise: $37.00Exp: 2010-11-17→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2006-01-04−10,000→ 0 total
    Exercise: $72.50Exp: 2010-02-25→ Common Stock (10,000 underlying)
Footnotes (26)
  • [F1]Disposed of pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005, in exchange for 0.203969 shares of EpiCept common stock and cash for fractional shares of EpiCept common stock equal to approximately $1.134 per share. Because there was no public market for the EpiCept common stock at the effective time of the merger, the market value of such stock was not determinable.
  • [F10]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $28.10 per share.
  • [F11]The option vested 100% on date of Grant.
  • [F12]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $47.07 per share.
  • [F13]The option vested 100% on 9/30/04.
  • [F14]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $47.07 per share.
  • [F15]The option vested 100% on 9/30/03.
  • [F16]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $15.94 per share.
  • [F17]The option vested 100% on 9/30/05.
  • [F18]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $8.05 per share.
  • [F19]The option vested 100% on date of Grant.
  • [F2]This option was cancelled pursuant to an Agreement and Plan of Merger among issuer, EpiCept Corporation and Magazine Acquisition Corp., dated September 6, 2005.
  • [F20]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 8,158 shares of EpiCept common stock for $18.39 per share.
  • [F21]The option vested 100% on date of Grant.
  • [F22]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 3,059 shares of EpiCept common stock for $77.22 per share.
  • [F23]The option vested 100% on date of Grant.
  • [F24]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 6,119 shares of EpiCept common stock for $25.50 per share.
  • [F25]The option vested 100% on date of Grant.
  • [F26]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 1,019 shares of EpiCept common stock for $45.36 per share.
  • [F3]The option vested 100% on date of Grant.
  • [F4]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 10,198 shares of EpiCept common stock for $39.23 per share.
  • [F5]The option vested 100% on date of Grant.
  • [F6]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $34.03 per share.
  • [F7]The option vested 100% on 9/30/01.
  • [F8]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,079 shares of EpiCept common stock for $34.03 per share.
  • [F9]The option vested 100% on 9/30/02.

Documents

1 file

Issuer

MAXIM PHARMACEUTICALS INC

CIK 0001013351

→
Entity typeother

Related Parties

1
  • filerCIK 0001215912

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 6:52 PM ET
Size
38.7 KB
View on SEC.gov